인비트로(In Vitro) 독성시험 시장 : 2027년까지의 세계 예측

출판 : MarketsandMarkets(마켓츠앤마켓츠)출판년월 : 2022년06월

인비트로(In Vitro) 독성시험 시장 : 제품[검정(웨스턴 블롯, 조직 배양), 기기, 소모품, 소프트웨어], 독성 지표(ADME, 피부 자극, 세포독성), 기술, 방법, 산업(제약, 바이오 기술) – 2027년까지의 세계 예측
In Vitro Toxicology Testing Market by Product (Assays (Western Blot, Tissue Culture), Equipment, Consumables, Software), Toxicity Endpoints (ADME, Skin Irritation, Cytotoxicity), Technology, Method, Industry (Pharma,Biotech) – Global Forecast to 2027

페이지수 356
도표수 376
구성 영문조사보고서
가격

리포트목차    주문/문의    납기/라이센스안내

Sample Request

The in vitro toxicology testing market is expected to reach USD 18.6 billion by 2027 from an estimated USD 11.2 billion in 2022, at a CAGR of 10.8%. Factors such as, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the factors to drive the market
인비트로(In Vitro) 독성시험 시장은 2022년 112억 달러에서 2027년까지 186억 달러에 이르러 10.8%의 CAGR로 성장할 것으로 예상됩니다. 기술 발전 및 약물 개발 초기 단계에서 독성을 감지하기 위한 R&D 비용 증가와 같은 요인이 시장을 주도하는 요인입니다.

“The ADME segment is expected to account for the largest market share in 2021.”
Based on toxicity endpoints and tests undertaken across all industries, the in vitro toxicity testing market is segmented into genotoxicity; cytotoxicity; ADME; skin irritation, corrosion, & sensitization; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endpoints & tests. In 2021, the ADME segment accounted for the largest share of the in vitro toxicity testing market.

“During the forecast period, the software segment is expected to grow at the highest rate.”
On the basis of product and service, the in vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services. Due to the increasing use of softwares in industry, the software segment is projected to witness the highest growth in the in vitro toxicology testing market during the forecast period.

“During the forecast period, toxicogenomics is expected to grow at the highest rate.”
During the forecast period, the toxicogenomics segment is expected to grow at the highest CAGR, due to the technological advancements taking place in the field of genomics and proteomics.

“In 2021, Europe is expected to hold the largest share for players operating in the in vitro toxicology testing market.”
In 2021, Europe accounted for the largest share of the in vitro toxicology testing market. Factors such as high adoption of in vitro toxicology testing assays and services in the chemical and cosmetics industries in the region are among the primary reasons expected to contribute to the growth of this market.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level (35%), Director-level (25%), and Others (40%)
• By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and the Middle East & Africa (2%)

Key players in the In Vito Toxiocology Testing Market

The prominent players in the in vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Laboratory Corporation of America Holdings (US), Bio-Rad Laboratories, Inc. (US), General Electric Company (US), Eurofins Scientific (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Evotec (UK), SGS S.A. (Switzerland), QIAGEN (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), MB Research Laboratories (US) ,Creative Biolabs(US), GVK Biosciences Private Limited (India), Shanghai Medicon Inc (China), Creative Biorray (US) and Insphero (Switzerland).


Research Coverage:
The report aims at estimating the market size and future growth potential of the global in vitro toxicology testing market and its product & service, technology, toxicity endpoint & test, industry, method, and regional segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in vitro toxicology testing market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global in vitro toxicology testing market
• Market Development: Comprehensive information on the lucrative emerging regions
• Market Diversification: Exhaustive information about the new product, growing geographies, and recent developments in the global in vitro toxicology testing market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, revenue analysis, and services of leading players in the global in vitro toxicology testing market


목차

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 44)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.2.2 MARKETS COVERED
FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 2 GLOBAL MARKET: GEOGRAPHIC SCOPE
1.2.3 YEARS CONSIDERED FOR STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS
1.5 LIMITATIONS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 49)
2.1 RESEARCH APPROACH
FIGURE 3 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION & VALIDATION APPROACH
FIGURE 5 MARKET SIZE APPROACH
FIGURE 6 BOTTOM-UP APPROACH
2.3 DATA TRIANGULATION APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR STUDY

3 EXECUTIVE SUMMARY (Page No. – 57)
FIGURE 8 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 GLOBAL MARKET, BY TOXICITY ENDPOINT & TEST, 2022 VS. 2027 (USD MILLION)
FIGURE 10 GLOBAL MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GLOBAL TING MARKET, BY INDUSTRY, 2022 VS. 2027 (USD MILLION)
FIGURE 12 GLOBAL MARKET, BY METHOD, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GEOGRAPHIC ANALYSIS: GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. – 62)
4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
FIGURE 14 OPPOSITION TO ANIMAL TESTING IS MAJOR FACTOR DRIVING MARKET GROWTH
4.2 ASIA PACIFIC: MARKET, BY METHOD
FIGURE 15 CELLULAR ASSAYS HELD LARGEST SHARE OF GLOBAL MARKET IN ASIA PACIFIC IN 2021
4.3 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 16 CHINA IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL MARKET DURING FORECAST PERIOD
4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
FIGURE 17 EUROPE WILL CONTINUE TO DOMINATE GLOBAL MARKET IN 2027
4.5 GLOBAL MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 18 DEVELOPING MARKETS TO REGISTER HIGHER CAGR THAN DEVELOPED MARKETS THROUGHOUT FORECAST PERIOD

5 MARKET OVERVIEW (Page No. – 66)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Public opposition to animal testing
5.2.1.2 Technological advancements in toxicology
5.2.1.3 R&D on early-stage toxicity detection
5.2.2 MARKET RESTRAINTS
5.2.2.1 Reluctance of some regulatory authorities to adopt alternative toxicology testing methods
5.2.2.2 Failure to establish intricacies of in-vivo conditions
5.2.2.3 Lack of in vitro models to study complex endpoints
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Growing focus on drug discovery and personalized medicine using in vitro methods
5.2.3.2 Increasing number of toxicology databases
5.2.4 MARKET CHALLENGES
5.2.4.1 Dearth of skilled professionals in toxicity testing

6 INDUSTRY INSIGHTS (Page No. – 72)
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
6.3 SUPPLY CHAIN ANALYSIS
FIGURE 20 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
6.4 REGULATORY COMMITTEE ACTIVITIES
6.4.1 MAJOR STAKEHOLDERS
6.4.2 KEY INFLUENCERS
6.5 COVID-19 IMPACT ON IN VITRO TOXICOLOGY MARKET
FIGURE 21 IMPACT OF COVID-19 ON GLOBAL MARKET
6.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 1 PORTER’S FIVE FORCES ANALYSIS
6.6.1 THREAT OF NEW ENTRANTS
6.6.2 THREAT OF SUBSTITUTES
6.6.3 BARGAINING POWER OF SUPPLIERS
6.6.4 DEGREE OF COMPETITIVE RIVALRY
6.7 TECHNOLOGY ANALYSIS

7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE (Page No. – 79)
    7.1 INTRODUCTION
7.2 COVID-19 IMPACT, BY PRODUCT & SERVICE
FIGURE 22 CONSUMABLES TO CAPTURE MAJORITY OF MARKET SHARE IN 2022
TABLE 2 GLOBAL MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 3 GLOBAL MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
7.3 CONSUMABLES
7.3.1 CONSUMABLES TO ACCOUNT FOR LARGER MARKET SHARE THAN OTHER PRODUCTS IN 2022
TABLE 4 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 5 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4 ASSAYS
TABLE 6 ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 7 ASSAYS: MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 8 ASSAYS: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 9 ASSAYS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.1 BACTERIAL TOXICITY ASSAYS
7.4.1.1 Bacterial assays to capture largest market share in coming years owing to their increasing adoption across several industries
TABLE 10 BACTERIAL TOXICITY ASSAYS: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 11 BACTERIAL TOXICITY ASSAYS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.2 ENZYME TOXICITY ASSAYS
7.4.2.1 Enzyme toxicity assays are increasingly used in endocrine-disrupting studies—major factor driving market growth
TABLE 12 ENZYME TOXICITY ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 13 ENZYME TOXICITY ASSAYS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.3 CELL-BASED ELISA & WESTERN BLOTS
7.4.3.1 Cell-based assays are cost-effective, thereby witnessing increasing adoption in drug discovery
TABLE 14 CELL-BASED ELISA & WESTERN BLOTS: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 15 CELL-BASED ELISA & WESTERN BLOTS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.4 RECEPTOR-BINDING ASSAYS
7.4.4.1 Receptor-binding assays are suitable for high-throughput formats, thereby exhibiting accelerated demand
TABLE 16 RECEPTOR-BINDING ASSAYS: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 17 RECEPTOR-BINDING ASSAYS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.5 TISSUE CULTURE ASSAYS
7.4.5.1 Tissue culture assays can mimic in-vivo tissue architecture, thereby attracting researchers
TABLE 18 TISSUE CULTURE ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 19 TISSUE CULTURE ASSAYS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.4.6 OTHER ASSAYS
TABLE 20 OTHER ASSAYS: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 21 OTHER ASSAYS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.5 EQUIPMENT
7.5.1 FULLY AUTOMATED IN VITRO TOXICOLOGY EQUIPMENT ARE INCREASINGLY ADOPTED IN RESEARCH
TABLE 22 EQUIPMENT: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 23 EQUIPMENT: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.6 SOFTWARE
7.6.1 SOFTWARE SOLUTIONS ARE VITAL IN REDUCING ANALYSIS TIME AND MANAGING LARGE VOLUMES OF DATA GENERATED DURING OPERATIONS
TABLE 24 SOFTWARE: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 25 SOFTWARE: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
7.7 SERVICES
7.7.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS
TABLE 26 SERVICES: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 27 SERVICES: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)

8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST (Page No. – 103)
    8.1 INTRODUCTION
FIGURE 23 ORGAN TOXICITY TESTING TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
TABLE 28 GLOBAL MARKET, BY TOXICITY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 29 GLOBAL MARKET, BY TOXICITY ENDPOINT & TEST, 2022–2027 (USD MILLION)
8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION)
8.2.1 ADME TESTING TO COMMAND GLOBAL MARKET DURING FORECAST PERIOD
TABLE 30 ADME: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 31 ADME: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION
8.3.1 SKIN IRRITATION, CORROSION, & SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN COSMETICS INDUSTRY
TABLE 32 SKIN IRRITATION, CORROSION, & SENSITIZATION: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 33 SKIN IRRITATION, CORROSION, & SENSITIZATION: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.4 GENOTOXICITY
8.4.1 REGULATORY AUTHORITIES REVIEW AND VALIDATE HIGHER NUMBER OF GENOTOXICITY TESTS THAN ANY OTHER ENDPOINT, THEREBY PROPELLING MARKET GROWTH
TABLE 34 GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 35 GENOTOXICITY: IN VITRO TOXICOLOGY TESTING, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.5 CYTOTOXICITY
8.5.1 RISING NEED FOR BIOSAFETY LARGELY CONTRIBUTES TO GROWTH OF CYTOTOXICITY TESTING MARKET
TABLE 36 CYTOTOXICITY: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 37 CYTOTOXICITY: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.6 OCULAR TOXICITY TESTING
8.6.1 IN VITRO AND EX-VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING
TABLE 38 OCULAR TOXICITY: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 39 OCULAR TOXICITY: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.7 ORGAN TOXICITY
8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY
TABLE 40 ORGAN TOXICITY: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 41 ORGAN TOXICITY: TE MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.8 PHOTOTOXICITY
8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE PHOTO SAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS
TABLE 42 PHOTOTOXICITY: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 43 PHOTOTOXICITY: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.9 DERMAL TOXICITY
8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN COMING YEARS
TABLE 44 DERMAL TOXICITY: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 45 DERMAL TOXICITY: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
8.10 OTHER ENDPOINTS & TESTS
TABLE 46 OTHER ENDPOINTS & TESTS: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 47 OTHER ENDPOINTS & TESTS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)

9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY (Page No. – 123)
    9.1 INTRODUCTION
FIGURE 24 TOXICOGENOMICS SEGMENT TO EXHIBIT HIGHEST CAGR IN  MARKET DURING FORECAST PERIOD
TABLE 48 GLOBAL MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 49 GLOBAL MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
9.2 CELL CULTURE
9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE WIDELY ADOPTED IN IN VITRO TESTING
TABLE 50 CELL CULTURE: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 51 CELL CULTURE: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
9.3 HIGH-THROUGHPUT
9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IN TOXICITY TESTING BOOSTS MARKET GROWTH
TABLE 52 HIGH-THROUGHPUT: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 53 HIGH-THROUGHPUT: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
9.4 TOXICOGENOMICS
9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ENHANCE STUDY OF GENES & PROTEIN ACTIVITIES DURING TOXICITY ANALYSIS
TABLE 54 TOXICOGENOMICS: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 55 TOXICOGENOMICS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)

10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY (Page No. – 131)
     10.1 INTRODUCTION
FIGURE 25 PHARMACEUTICALS & BIOPHARMACEUTICALS INDUSTRY TO HOLD LARGEST MARKET SHARE THROUGHOUT FORECAST PERIOD
TABLE 56 GLOBAL MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 57 GLOBAL MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
10.2 COVID-19 IMPACT, BY INDUSTRY
10.3 PHARMACEUTICALS & BIOPHARMACEUTICALS
10.3.1 DRUG ATTRITION RATE LEADS TO HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN EARLY STAGES OF DRUG DEVELOPMENT
TABLE 58 PHARMACEUTICALS & BIOPHARMACEUTICALS: GLOBAL MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 59 PHARMACEUTICALS & BIOPHARMACEUTICALS: GLOBAL MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
10.4 COSMETICS & HOUSEHOLD PRODUCTS
10.4.1 BAN ON ANIMAL TESTING LEADING TO ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING
TABLE 60 COSMETICS & HOUSEHOLD PRODUCTS: GLOBAL MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 61 COSMETICS & HOUSEHOLD PRODUCTS: GLOBAL MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
10.5 FOOD
10.5.1 INCREASING FOCUS ON FOOD SAFETY DRIVES REQUIREMENT FOR IN VITRO TOXICOLOGY TESTING PRODUCTS
TABLE 62 TYPES OF TOXICOLOGY TESTS IN FOOD
TABLE 63 FOOD: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 64 FOOD: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
10.6 CHEMICALS
10.6.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICALS TESTING PROPELS MARKET GROWTH
TABLE 65 CHEMICALS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 66 CHEMICALS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)

11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD (Page No. – 144)
11.1 INTRODUCTION
FIGURE 26 IN-SILICO MODELS TO RECORD HIGHEST CAGR IN IN VITRO TOXICOLOGY TESTING MARKET DURING FORECAST PERIOD
TABLE 67 GLOBAL MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 68 GLOBAL MARKET, BY METHOD, 2022–2027 (USD MILLION)
11.2 CELLULAR ASSAYS
11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
TABLE 69 CELLULAR ASSAYS: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 70 CELLULAR ASSAYS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
11.3 BIOCHEMICAL ASSAYS
11.3.1 BIOCHEMICAL ASSAYS ARE ADOPTED AT HIGHER RATE IN PHARMACEUTICALS INDUSTRY THAN CHEMICALS AND FOOD INDUSTRIES
TABLE 71 BIOCHEMICAL ASSAYS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 72 BIOCHEMICAL ASSAYS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
11.4 IN-SILICO MODELS
11.4.1 IN-SILICO MODELS ARE EXPECTED TO WITNESS HIGHEST CAGR FROM 2022 TO 2027
TABLE 73 IN-SILICO MODELS: MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 74 IN-SILICO MODELS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)
11.5 EX-VIVO MODELS
11.5.1 EX-VIVO MODELS ARE WIDELY USED IN SKIN AND EYE TOXICOLOGY TESTING IN COSMETICS INDUSTRY
TABLE 75 EX-VIVO MODELS: IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHY, 2019–2021 (USD MILLION)
TABLE 76 EX-VIVO MODELS: MARKET, BY GEOGRAPHY, 2022–2027 (USD MILLION)

12 IN VITRO TOXICOLOGY TESTING MARKET, BY GEOGRAPHIC ANALYSIS (Page No. – 155)
12.1 INTRODUCTION
12.2 COVID-19 IMPACT, BY REGION
FIGURE 27 GLOBAL MARKET: GEOGRAPHIC SNAPSHOT
TABLE 77 GLOBAL MARKET, BY REGION, 2019–2021 (USD MILLION)
TABLE 78 GLOBAL MARKET, BY REGION, 2022–2027 (USD MILLION)
12.3 EUROPE
FIGURE 28 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
TABLE 79 EUROPE: MARKET, BY COUNTRY, 2019–2021 (USD MILLION)
TABLE 80 EUROPE: MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 81 EUROPE: MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 82 EUROPE: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 83 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 84 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 85 EUROPE: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 86 EUROPE: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 87 EUROPE: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 88 EUROPE: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 89 EUROPE: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 90 EUROPE: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 91 EUROPE: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 92 EUROPE: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.3.1 GERMANY
12.3.1.1 Germany holds the largest share of the European market
TABLE 93 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 94 GERMANY: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 95 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,  2019–2021 (USD MILLION)
TABLE 96 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 97 GERMANY: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 98 GERMANY: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 99 GERMANY: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 100 GERMANY: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 101 GERMANY: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 102 GERMANY: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 103 GERMANY: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 104 GERMANY: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.3.2 UK
12.3.2.1 Rising awareness, growing R&D, and increasing collaborations for In Vitro Toxicology Testing Market are key indicators of market growth in UK
TABLE 105 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 106 UK: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 107 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 108 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022-2027 (USD MILLION)
TABLE 109 UK: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 110 UK: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 111 UK: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 112 UK: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 113 UK: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 114 UK: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 115 UK: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 116 UK: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.3.3 FRANCE
12.3.3.1 Proteomics research initiatives supported by government aid market growth in France
TABLE 117 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 118 FRANCE: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 119 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,  2019–2021 (USD MILLION)
TABLE 120 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 121 FRANCE: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 122 FRANCE: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 123 FRANCE: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 124 FRANCE: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 125 FRANCE: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 126 FRANCE: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 127 FRANCE: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 128 FRANCE: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.3.4 ITALY
12.3.4.1 Italian market growth is mainly driven by increased volume of life sciences research
TABLE 129 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 130 ITALY: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 131 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 132 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 133 ITALY: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 134 ITALY: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 135 ITALY: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 136 ITALY: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 137 ITALY: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 138 ITALY: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 139 ITALY: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 140 ITALY: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.3.5 SPAIN
12.3.5.1 Spain’s growing Chemicals industry stimulates in vitro toxicology testing market growth
TABLE 141 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 142 SPAIN: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 143 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 144 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 145 SPAIN: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 146 SPAIN: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 147 SPAIN: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 148 SPAIN: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 149 SPAIN: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 150 SPAIN: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 151 SPAIN: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 152 SPAIN: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.3.6 REST OF EUROPE
TABLE 153 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 154 REST OF EUROPE: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 155 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 156 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 157 REST OF EUROPE: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 158 REST OF EUROPE: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 159 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 160 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 161 REST OF EUROPE: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 162 REST OF EUROPE: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 163 REST OF EUROPE: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 164 REST OF EUROPE: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.4 NORTH AMERICA
FIGURE 29 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
TABLE 165 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2021 (USD MILLION)
TABLE 166 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 167 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 168 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 169 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 170 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 171 NORTH AMERICA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 172 NORTH AMERICA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 173 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 174 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 175 NORTH AMERICA: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 176 NORTH AMERICA: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 177 NORTH AMERICA: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 178 NORTH AMERICA: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.4.1 US
12.4.1.1 US dominates North American market due to growing focus on biomarker discovery and research in structure-based drug design
TABLE 179 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 180 US: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 181 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 182 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 183 US: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 184 US: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 185 US: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 186 US: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 187 US: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 188 US: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 189 US: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 190 US: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.4.2 CANADA
12.4.2.1 Strong support to carry out R&D in pharmaceutical and proteomics fields fosters market growth in Canada
TABLE 191 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 192 CANADA: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 193 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 194 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 195 CANADA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 196 CANADA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 197 CANADA: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 198 CANADA: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 199 CANADA: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 200 CANADA: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 201 CANADA: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 202 CANADA: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.5 ASIA PACIFIC
FIGURE 30 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
TABLE 203 ASIA PACIFIC:MARKET, BY COUNTRY, 2019–2021 (USD MILLION)
TABLE 204 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2027 (USD MILLION)
TABLE 205 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 206 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 207 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 208 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 209 ASIA PACIFIC: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 210 ASIA PACIFIC: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 211 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 212 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 213 ASIA PACIFIC: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 214 ASIA PACIFIC: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 215 ASIA PACIFIC: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 216 ASIA PACIFIC: MARKET, BY METHOD,  2022–2027 (USD MILLION)
12.5.1 CHINA
12.5.1.1 Increasing international pressure to ban animal testing methods will propel market growth in coming years
TABLE 217 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 218 CHINA: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 219 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 220 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 221 CHINA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 222 CHINA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 223 CHINA: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 224 CHINA: MARKET, BY TECHNOLOGY,  2022–2027 (USD MILLION)
TABLE 225 CHINA: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 226 CHINA: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 227 CHINA: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 228 CHINA: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.5.2 JAPAN
12.5.2.1 Use of artificial skin patches and plates of cultured human cells has increased demand for in vitro toxicology testing products in Japan
TABLE 229 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 230 JAPAN: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 231 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 232 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 233 JAPAN: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 234 JAPAN: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 235 JAPAN: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 236 JAPAN: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 237 JAPAN: MARKET, BY INDUSTRY,  2019–2021 (USD MILLION)
TABLE 238 JAPAN: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 239 JAPAN: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 240 JAPAN: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.5.3 INDIA
12.5.3.1 Growing focus of universities on avoiding use of animals to test cosmetic products is likely to propel market growth
TABLE 241 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 242 INDIA: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 243 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 244 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 245 INDIA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 246 INDIA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 247 INDIA: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 248 INDIA: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 249 INDIA: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 250 INDIA: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 251 INDIA: IN VITRO TRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 252 INDIA: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.5.4 REST OF ASIA PACIFIC
TABLE 253 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 254 REST OF ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 255 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 256 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 257 REST OF ASIA PACIFIC: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 258 REST OF ASIA PACIFIC: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 259 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 260 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 261 REST OF ASIA PACIFIC: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 262 REST OF ASIA PACIFIC: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 263 REST OF ASIA PACIFIC: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 264 REST OF ASIA PACIFIC: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.6 LATIN AMERICA
12.6.1 LOW COST OF DRUG TRIALS HAVE MADE LATIN AMERICA POPULAR OUTSOURCING MARKET
TABLE 265 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 266 LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 267 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 268 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 269 LATIN AMERICA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 270 LATIN AMERICA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 271 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 272 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 273 LATIN AMERICA: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 274 LATIN AMERICA: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 275 LATIN AMERICA: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 276 LATIN AMERICA: MARKET, BY METHOD, 2022–2027 (USD MILLION)
12.7 MIDDLE EAST & AFRICA
12.7.1 INCREASING R&D INVESTMENTS AND FOCUS ON DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
TABLE 277 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019–2021 (USD MILLION)
TABLE 278 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT & SERVICE, 2022–2027 (USD MILLION)
TABLE 279 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2019–2021 (USD MILLION)
TABLE 280 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2022–2027 (USD MILLION)
TABLE 281 MIDDLE EAST & AFRICA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2019–2021 (USD MILLION)
TABLE 282 MIDDLE EAST & AFRICA: MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2022–2027 (USD MILLION)
TABLE 283 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2019–2021 (USD MILLION)
TABLE 284 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2022–2027 (USD MILLION)
TABLE 285 MIDDLE EAST & AFRICA: MARKET, BY INDUSTRY, 2019–2021 (USD MILLION)
TABLE 286 MIDDLE EAST & AFRICA: MARKET, BY INDUSTRY, 2022–2027 (USD MILLION)
TABLE 287 MIDDLE EAST & AFRICA: MARKET, BY METHOD, 2019–2021 (USD MILLION)
TABLE 288 MIDDLE EAST & AFRICA: MARKET, BY METHOD, 2022–2027 (USD MILLION)

13 COMPETITIVE LANDSCAPE (Page No. – 264)
     13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 31 KEY DEVELOPMENTS IN IN VITRO TOXICOLOGY TESTING MARKET, 2019–2022
13.3 MARKET SHARE ANALYSIS
FIGURE 32 GLOBAL MARKET SHARE, BY KEY PLAYER, 2021
TABLE 289 GLOBAL MARKET: DEGREE OF COMPETITION
13.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
13.5 COMPANY EVALUATION QUADRANT
13.5.1 STAR
13.5.2 EMERGING LEADER
13.5.3 PERVASIVE
13.5.4 PARTICIPANT
FIGURE 34 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION QUADRANT, 2021
13.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
13.6.1 PROGRESSIVE COMPANY
13.6.2 STARTING BLOCK
13.6.3 RESPONSIVE COMPANY
13.6.4 DYNAMIC COMPANY
FIGURE 35 IN VITRO TOXICITY MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021
13.7 COMPANY FOOTPRINT ANALYSIS
13.7.1 COMPANY PRODUCT FOOTPRINT
TABLE 290 COMPANY PRODUCT FOOTPRINT: IN VITRO TOXICOLOGY TESTING MARKET (2021)
13.8 COMPANY REGIONAL FOOTPRINT
TABLE 291 COMPANY REGIONAL FOOTPRINT: GLOBAL MARKET (2021)
13.9 COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
TABLE 292 GLOBAL MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 293 GLOBAL MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
13.10 COMPETITIVE SCENARIO
TABLE 294 PRODUCT LAUNCHES
TABLE 295 DEALS
TABLE 296 OTHER DEVELOPMENTS

14 COMPANY PROFILES (Page No. – 278)
     14.1 MAJOR PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 297 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
14.1.2 MERCK KGAA
TABLE 298 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 37 MERCK KGAA: COMPANY SNAPSHOT (2021)
14.1.3 EUROFINS SCIENTIFIC SE
TABLE 299 EUROFINS SCIENTIFIC SE: BUSINESS OVERVIEW
FIGURE 38 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
14.1.4 GENERAL ELECTRIC COMPANY
TABLE 300 GENERAL ELECTRIC COMPANY: BUSINESS OVERVIEW
FIGURE 39 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2021)
14.1.5 LABORATORY CORPORATION OF AMERICA HOLDINGS
TABLE 301 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW
FIGURE 40 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2021)
14.1.6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
TABLE 302 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW
FIGURE 41 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021)
14.1.7 SGS SA
TABLE 303 SGS SA: BUSINESS OVERVIEW
FIGURE 42 SGS SA: COMPANY SNAPSHOT (2021)
14.1.8 BIO-RAD LABORATORIES, INC.
TABLE 304 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
14.1.9 QIAGEN
TABLE 305 QIAGEN: BUSINESS OVERVIEW
FIGURE 44 QIAGEN: COMPANY SNAPSHOT (2021)
14.1.10 EVOTEC AG
TABLE 306 EVOTEC AG: BUSINESS OVERVIEW
FIGURE 45 EVOTEC AG: COMPANY SNAPSHOT (2021)
14.1.11 PROMEGA CORPORATION
TABLE 307 PROMEGA CORPORATION.: BUSINESS OVERVIEW
14.1.12 CATALENT, INC.
TABLE 308 CATALENT, INC.: BUSINESS OVERVIEW
FIGURE 46 CATALENT, INC.: COMPANY SNAPSHOT (2021)
14.2 OTHER COMPANIES
14.2.1 GENTRONIX LIMITED
TABLE 309 GENTRONIX LIMITED: COMPANY OVERVIEW
14.2.2 MB RESEARCH LABORATORIES
TABLE 310 MB RESEARCH LABORATORIES: COMPANY OVERVIEW
14.2.3 BIOIVT
TABLE 311 BIOIVT: COMPANY OVERVIEW
14.2.4 CREATIVE BIOLABS
TABLE 312 CREATIVE BIOLABS: COMPANY OVERVIEW
14.2.5 GVK BIOSCIENCES PRIVATE LIMITED
TABLE 313 GVK BIOSCIENCES PRIVATE LIMITED: COMPANY OVERVIEW
14.2.6 SHANGHAI MEDICILON INC.
TABLE 314 SHANGHAI MEDICILON INC.: COMPANY OVERVIEW
14.2.7 CREATIVE BIOARRAY
TABLE 315 CREATIVE BIOARRAY: COMPANY OVERVIEW
14.2.8 INSPHERO
TABLE 316 INSPHERO: COMPANY OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

15 RELATED MARKETS (Page No. – 345)
15.1 INTRODUCTION
15.2 IN VIVO TOXICITY MARKET
15.2.1 MARKET DEFINITION
15.2.2 LIMITATIONS
15.2.3 MARKET OVERVIEW
FIGURE 47 CONSUMABLES SEGMENT WILL CONTINUE TO DOMINATE THE IN VIVO TOXICOLOGY MARKET DURING THE FORECAST PERIOD
15.3 IN VIVO TOXICOLOGY MARKET, BY PRODUCT
15.3.1 CONSUMABLES
TABLE 317 IN VIVO TOXICITY CONSUMABLES MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.3.2 INSTRUMENTS
TABLE 318 IN VIVO TOXICOLOGY INSTRUMENTS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4 IN VIVO TOXICITY MARKET, BY TOXICITY ENDPOINT
15.4.1 IMMUNOTOXICITY
TABLE 319 IN VIVO TOXICOLOGY MARKET FOR IMMUNOTOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.2 SYSTEMIC TOXICITY
TABLE 320 IN VIVO TOXICOLOGY MARKET FOR SYSTEMIC TOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.3 CARCINOGENICITY
TABLE 321 IN VIVO TOXICOLOGY MARKET FOR CARCINOGENICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.4 GENOTOXICITY
TABLE 322 IN VIVO TOXICOLOGY MARKET FOR GENOTOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.5 DEVELOPMENTAL AND REPRODUCTIVE TOXICITY (DART)
TABLE 323 IN VIVO TOXICOLOGY MARKET FOR DEVELOPMENTAL AND REPRODUCTIVE TOXICITY, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.4.6 OTHER TOXICITY ENDPOINTS
TABLE 324 IN VIVO TOXICOLOGY MARKET FOR OTHER TOXICITY ENDPOINTS, BY COUNTRY/REGION, 2015–2022 (USD MILLION)
15.5 IN VIVO TOXICITY MARKET, BY REGION
15.5.1 NORTH AMERICA
TABLE 325 NORTH AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015–2022 (USD MILLION)
15.5.2 EUROPE
TABLE 326 EUROPE: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015–2022 (USD MILLION)
15.5.3 ASIA PACIFICASIA PACIFIC
TABLE 327 ASIA PACIFIC: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015–2022 (USD MILLION)
15.5.4 LATIN AMERICA
TABLE 328 LATIN AMERICA: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015–2022 (USD MILLION)
15.5.5 MIDDLE EAST & AFRICA
TABLE 329 MIDDLE EAST & AFRICA: IN VIVO TOXICOLOGY MARKET, BY TOXICOLOGY ENDPOINT, 2015–2022 (USD MILLION)

16 APPENDIX (Page No. – 360)
     16.1 INSIGHTS OF INDUSTRY EXPERTS
16.2 DISCUSSION GUIDE
16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.4 AVAILABLE CUSTOMIZATIONS
16.5 RELATED REPORTS
16.6 AUTHOR DETAILS


    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com